Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
From Benzinga
Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal
July 07, 2023
Tickers
FLHLF
From Benzinga
Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures
July 06, 2023
Tickers
CMPS
From Benzinga
Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next
July 05, 2023
Tickers
AWKNF
From Benzinga
80% Of US Voters Support Easing Research Restrictions, Plus Other Insights From UC-Berkeley Poll
July 05, 2023
From Benzinga
Inside UC Berkeley's Nation-Representative Psychedelics Survey: Unveiling Unexpected Data
July 05, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
July 02, 2023
From Benzinga
Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3
June 29, 2023
From Benzinga
This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches
June 28, 2023
Tickers
LOBEF
From Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
June 28, 2023
From Benzinga
Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
June 28, 2023
Tickers
CYBN
From Benzinga
Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets
June 27, 2023
From Benzinga
Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines
June 27, 2023
Tickers
DSNKY
From Benzinga
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression
June 27, 2023
Tickers
MSSTF
From Benzinga
MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld
June 27, 2023
Tickers
MNMD
From Benzinga
$100M Investment & Donation To Psychedelics Research From Toms Shoes Founder Blake Mycoskie
June 27, 2023
From Benzinga
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
June 20, 2023
From Benzinga
From Benzinga
Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement
June 15, 2023
Tickers
AWKNF
From Benzinga
Nevada Governor Passes Psychedelics Bill To Form New Working Group And Future Regulated Access
June 15, 2023
From Benzinga
Federal Psychedelics: $75M Grant Program, NIDA's Special Interest In State & Local Reform
June 14, 2023
From Benzinga
Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M
June 13, 2023
Tickers
PMBHF
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.